Sigma share price dips on CFO resignation news

The Sigma Healthcare Ltd (ASX:SIG) share price sunk lower today following the resignation of the company's CFO.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Sigma Healthcare Ltd (ASX: SIG) share price has closed today's trading session slightly lower after it was announced that the company's CFO is resigning.  

What did Sigma announce?

Sigma Healthcare announced earlier today that the company's CFO Iona MacPherson has resigned, effective immediately. According to the announcement, Ms MacPherson will depart the company by mutual agreement after occupying the position since November 2016.  

The announcement acknowledged that the resignation of the company's CFO was bad timing, however management reassured investors that it will not impact Sigma's trading performance. Sigma's chief executive Mark Hopper reassured shareholders, stating:

Sales for December and early January have continued to be strong and we remain on target to meet our existing guidance of $46-47 million underlying EBITDA and to accelerate our growth through FY21.

Sigma has already started an external search for a new CFO. In the interim, former CFO and current retail pharmacy general manager Jeff Sells will step into the role. In response to the resignation news, the Sigma share price fell more than 2% in early trade, before recovering slightly at the end of today's trading session.

Why is this a bad time for the CFO to resign?

Sigma owns a portfolio of chemist retailing outlets including Amcal, Chemist King and the Discount Drug Store brand. The pharmacy operator failed to extend a supply contract with retail giant Chemist Warehouse in mid-2018. Since then, Sigma has been embarked on a costly restructuring of the company and has faced numerous tailwinds, which has seen its share price suffer.

The loss of the supply contract was reflected in Sigma's interim report last September. The company reported an 80% fall in interim profit of $2.55 million, whilst also announcing that it will slash 500 jobs.

Late last year, Sigma also rejected a takeover bid from Australian Pharmaceutical Industries Ltd (ASX: API). As a result, the company's share price suffered a further decline after API sold their 11% stake in Sigma.

In its bid to restructure the company, Sigma aims to deliver more than $100 million in efficiency gains after losing its supply contract. The company estimates that underlying EBITDA for FY20 will be at the low end of its previous guidance of between $55–60 million. Earnings for FY21 remain in line with previous guidance, with Sigma expecting at least 10% growth.

The Sigma share price closed down 0.85% at $0.58 per share.

Motley Fool contributor Nikhil Gangaram has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Person pretends to types on laptop drawn in sand.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a miserly session for investors today.

Read more »

Modern accountant woman in a light business suit in modern green office with documents and laptop.
Opinions

Too high? These 2 ASX shares might be due for a correction

These popular blue chips are looking dicey to me.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Broker Notes

These ASX 200 shares could rise 20% to 35%

These shares are being tipped to deliver market-beating returns by analysts.

Read more »

Keyboard button with the word sell on it.
Broker Notes

8 ASX All Ords stocks downgraded to sell ratings

Find out which shares are out of favour with the experts.

Read more »

Woman smiling whilst shopping in a clothing store.
Dividend Investing

Why this quality ASX 300 dividend stock is tipped to surge 54%

A leading fund manager forecasts significant outperformance from this quality ASX 300 dividend stock.

Read more »

A group of businesspeople clapping.
Broker Notes

Bell Potter names more of the best ASX 200 stocks to buy in June

These stocks could be best buys this month according to the broker.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Market News

Why Clarity, Coronado Global, Iperionx, and Lynas shares are roaring higher today

These shares are having a strong session on Thursday. Why are investors buying them?

Read more »

A woman looks questioning as she puts a coin into a piggy bank.
Opinions

The ASX 200 is approaching its all-time high. Here's why I'm not buying shares

I'm not seeing what the broader market is.

Read more »